Mazen Noureddin, MD, MHSc, is a Professor of Medicine and an internationally recognized leader in Steatotic Liver Disease (SLD) and SLD-related cirrhosis. He completed his internal medicine residency at the University of Southern California (USC), followed by advanced hepatology training at the National Institutes of Health (NIH) within the NIDDK Liver Diseases Branch, where he also earned an NIH/Duke Master of Health Sciences in Clinical Research. He subsequently completed a gastroenterology fellowship at the University of California, San Diego (UCSD) as a T32 NIH fellow.

Dr. Scherer completed a combined Transplant Hepatology and Gastroenterology Fellowship at Indiana University School of Medicine in June 2026, after which he took a position as Assistant Professor of Clinical Medicine at Indiana University School of Medicine. In his work as a transplant hepatologist, his clinical and clinical research interests focus on improving patient outcomes after liver transplantation. He currently serves on the AASLD Training and Workforce Committee.

Dr Jennifer Guy MD MAS is a transplant hepatologist and Director of the Liver Cancer Program at California Pacific Medical Center. She is the Kranzusch Bosworth Endowed Chair for Innovation in Transplant Medicine with a focus on optimizing the patient experience.

Rotonya McCants Carr, MD is the Cyrus E. Rubin Chair and Division Head of Gastroenterology at the University of Washington. She is a basic science researcher and clinical hepatologist who specializes in the care of patients with fatty liver diseases. Her laboratory uses complementary in vivo and cellular approaches to investigate the mechanisms of insulin resistance in metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and alcohol-associated liver disease (ALD). Dr.

Guadalupe Garcia-Tsao, MD, FRCP is Professor of Medicine at Yale University School of Medicine and the VA-Connecticut Healthcare System. She is Associate Editor for the New England Journal of Medicine, was AASLD President in 2012 when she initiated the Emerging Liver Scholar Program and Chair of the recent Baveno VIII conference. Dr. Garcia-Tsao's research focuses on cirrhosis, portal hypertension, risk stratification and complications. She has authored over 200 original research publications and numerous society guidelines and position papers, with an h-index of 107.

Teresa (Terry) Wright is currently Vice President for Clinical Research Infectious Diseases at Vir Biotechnology with responsibility for oversight of clinical development of investigational agents for patients with viral liver diseases.

Dr. Lok graduated from the University of Hong Kong Medical School. She completed her hepatology training in London under Dame Sheila Sherlock. She was on the faculty at the University of Hong Kong until she moved to the United States in 1992.

Dr. Lok's research focuses on natural history and treatment of hepatitis B and C. She has published more than 650 papers.

H. Marvin Pollard Collegiate Professor of Gastroenterology III
Professor of Internal Medicine and Surgery
Director, Morphomics Analysis Group
University of Michigan Medical School

Chief, Gastroenterology and Hepatology Section
Associate Chief of Specialty Care and Access, Medicine Service
VA Ann Arbor Healthcare System

I happily wear the label of physician-scientist and am on the faculty of Keck Medicine of the University of Southern California. Rather than describing myself, I would rather tell you about some of our research. Since my Fellowship, my basic science has focused on the liver sinusoidal endothelial cell, the LSEC.

Dr. Thomas Reiberger is a Professor of Gastroenterology and Hepatology at the Medical University of Vienna and holds medical boards for Internal Medicine, Gastroenterology/Hepatology and ICU. He leads the advanced chronic liver disease (ACLD) program at the Vienna General Hospital, including outpatient clinics for patients with liver cirrhosis, portal hypertension, and for pre-post liver transplantation care. As a physician scientist he performs invasive transjugular procedures, endoscopic GI and hepatobiliary interventions and engages in intensive care management of GI/Liver patients.